Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Stem Cell Transplant + Bortezomib for Blood Cancer
Recruiting1 awardPhase 2
Detroit, Michigan
This trial is testing a new way to do stem cell transplants for people with blood cancers who don't have a matching donor. The new method uses a haploidentical (partially matched) donor, and post-transplant cyclophosphamide and bortezomib. The goal is to see if this method leads to successful engraftment (when transplanted cells start to grow and make new blood cells).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service